review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Pommier Y | |
Kohn KW | |||
Tanizawa A | |||
P304 | page(s) | 73-92 | |
P577 | publication date | 1994-01-01 | |
P1433 | published in | Advances in Pharmacology | Q15753809 |
P1476 | title | Mechanisms of topoisomerase I inhibition by anticancer drugs | |
P478 | volume | 29B |
Q37257775 | A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases |
Q38273585 | Differential expression of topoisomerase I and RAD52 protein in yeast reveals new facets of the mechanism of action of bisdioxopiperazine compounds |
Q41161962 | Discovery of DNA Topoisomerase I Inhibitors with Low-Cytotoxicity Based on Virtual Screening from Natural Products. |
Q28361246 | Effects of the combination of camptothecin and doxorubicin or etoposide on rat glioma cells and camptothecin-resistant variants |
Q28368205 | Identification of the aminocatechol A-3253 as an in vitro poison of DNA topoisomerase I from Candida albicans |
Q39718939 | In the presence of subunit A inhibitors DNA gyrase cleaves DNA fragments as short as 20 bp at specific sites |
Q37121596 | Induction of topoisomerase I cleavage complexes by 1-beta -D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cells |
Q36568915 | Iron chelators with topoisomerase-inhibitory activity and their anticancer applications |
Q41682184 | Nitric oxide inhibits ATPase activity and induces resistance to topoisomerase II-poisons in human MCF-7 breast tumor cells |
Q37008894 | Nitric oxide inhibits topoisomerase II activity and induces resistance to topoisomerase II-poisons in human tumor cells |
Q27021105 | Review of systemic therapies for locally advanced and metastatic rectal cancer |
Q40173309 | Schedule-dependent cytotoxicity of 5-fluorouracil and irinotecan in a colon cancer cell line |
Q46273019 | Synergistic enhancement of topotecan-induced cell death by ascorbic acid in human breast MCF-7 tumor cells. |
Q28379054 | Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts |
Search more.